Solugen
Houston, United States· Est.
Solugen uses bio‑engineered enzymes and metal catalysts to produce sustainable, high‑yield industrial chemicals at scale.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Estimated funding: $640M
AI Company Overview
Solugen uses bio‑engineered enzymes and metal catalysts to produce sustainable, high‑yield industrial chemicals at scale.
Technology Platform
A proprietary Bioforge system that couples AI‑optimized, cell‑free enzymatic oxidation with engineered heterogeneous metal catalysts to convert bio‑derived feedstocks into high‑yield industrial chemicals.
Opportunities
Expansion of modular Bioforge units into new geographies and diversification into higher‑value specialty chemicals.
Risk Factors
Technical scaling of cell‑free biocatalysis and competition from other sustainable chemical platforms.
Competitive Landscape
Competes with firms like LanzaTech, Ginkgo Bioworks, and Amyris, differentiating through its integrated enzyme‑metal catalyst system and modular manufacturing approach.